Liver Disease
Article
MASLD/MASH and Weight Loss
Supplements
Gastroenterology Data Trends 2023
From the AGA Journals
AGA CPU focuses on noninvasive tests in patients with NAFLD
Noninvasive tests in GI have the potential to improve the detection of advanced fibrosis.
From the AGA Journals
Hepatic presentations of celiac disease
Liver biopsy findings may include variable degrees of steatosis, inflammation, and fibrosis.
From the Journals
New guide for acute liver failure urges early treatment, transplant referral
The clinical guidelines focus on the diagnosis and management of patients with acute liver failure.
From the Journals
Bulevirtide shows promise in chronic hepatitis D
There is no approved treatment for a hepatitis D virus infection which affects between 10 and 20 million people worldwide.
From the Journals
Two-pronged approach needed in alcohol-associated hepatitis
Patients are likely to carry a dual diagnosis of liver disease and alcohol use disorder.
In Focus
Navigating NAFLD: Unveiling the approach to mitigate the impact of NAFLD
According to the Centers for Disease Control and Prevention, there have been substantial increases in liver-related deaths over the last two...
Latest News
Naltrexone is safe and beneficial in AUD with cirrhosis
VIENNA –
Pearls from the Pros
Incidental hepatic steatosis
It is important to identify patients at risk of progressive fibrosis.